What is CirQuest Labs?
CirQuest Labs operates as a premier provider of full-service central laboratory solutions, catering to the complex requirements of global clinical trials. The company distinguishes itself through a robust infrastructure that encompasses specialty testing, biomarker assay development, and sophisticated biological sample management. By integrating global logistics with high-precision laboratory capabilities, CirQuest Labs serves as a vital partner for biotech and pharmaceutical entities aiming to optimize drug development timelines. Their adherence to rigorous CAP/CLIA standards ensures that data integrity remains at the forefront of their service delivery, supporting thousands of trials across diverse international markets.
How much funding has CirQuest Labs raised?
CirQuest Labs has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in CirQuest Labs
PPP
Public-Private Partnership
What's next for CirQuest Labs?
With this recent capital deployment, CirQuest Labs is expected to scale its biomarker development capabilities and expand its global logistics network. The strategic focus will likely shift toward enhancing automated sample storage solutions and deepening its integration with decentralized clinical trial models. As the pharmaceutical industry continues to prioritize high-quality data and rapid trial execution, CirQuest Labs is poised to leverage its current financial stability to capture additional market share and solidify its status as an essential infrastructure provider in the life sciences value chain.
See full CirQuest Labs company page
